Bill > AB926

This bill amends California's Health and Safety Code to allow compensation for women who provide human oocytes, which are eggs, for research purposes, reversing a previous ban. The bill clarifies that compensation is for the woman's time, discomfort, and inconvenience, not for the oocytes themselves, and that the amount will be determined by human subject research panels or institutional review boards, which are committees that review research involving people to ensure ethical standards are met. It also establishes conditions under which compensation for fertility treatments would not affect the eligibility of excess oocytes or embryos for research, aiming to facilitate reproductive research that could benefit women undergoing fertility treatments like in vitro fertilization (IVF) by improving embryo quality and reducing multiple pregnancies.